Published data on the relationship between E-cadherin (CDH1) gene promoter polymorphisms and colorectal cancer (CRC) risk are inconclusive. To derive a more precise estimation of the relationship, a meta-analysis was carried out. In this meta-analysis, we evaluated reported studies of associations between polymorphisms of CDH1 gene promoter −16 C > A and −347 G > GA site, and CRC risk using fixed-effects model and random-effects model. We found decreased CRC risk among subjects carrying CDH1−16AA (odds ratio [OR] = .86, 95 percent confidence interval [95% CI]: .75–.98) and CA + AA (OR = .92, 95% CI: .87–.98), using 4,652/4,428 cases/controls and 7,866/7,689 cases/controls from ten studies, respectively. We found a protective effect of the CDH1−16CA + AA polymorphisms for CRC in distal site tumor population and population-based control in stratified analysis. We found a protective effect of the CDH1−16AA and CA + AA polymorphisms for CRC in European and American population (OR = .87, 95% CI: .76–.99 and OR = .91, 95% CI: .85–.98, respectively). We observed that the CDH1−347 G/GA + GA/GA carrier had an increased risk of CRC, the summary OR was 1.33 (95% CI: 1.8–1.62). Data indicated that certain CDH1 gene promoter −16 C > A and −347 G > GA variants might affect the susceptibility of CRC. Recommendations for further studies include pooling of individual data to facilitate evaluation of multigenic effects and detailed analysis of effect modification by environmental and lifestyle factors.
Related Content
Effects of Smoking and Obesity on the Association Between CDH13 (rs3865188) and Adiponectin Among Korean Men: The KARE Study
Adiponectin is secreted exclusively by adipocytes. Adiponectin is regulated by obesity, smoking, and genetic factors, including CDH13, which may contribute to development of diseases such as cardiovascular disease. Therefore, we aim to explore the joint effect of smoking and obesity on the associ...


Usefulness of plasma epigenetic changes of five major genes involved in the pathogenesis of colorectal cancer
The purpose of present study was to investigate the methylation status of the promoter region in five genes (mothers against decapentaplegic homolog 4, fragile histidine triad protein, death-associated protein kinase 1, adenomatous polyposis coli (APC), and E-cadherin), which are known to be invo...
HTERT promoter polymorphism, -1327C>T, is associated with the risk of epithelial cancer
Telomeres are repetitive nucleotide sequences that cap the end of eukaryotic chromosomes. Attrition of these structures has been associated with carcinogenesis in many tissues, and therefore, they are essential for chromosome stabilization. Telomeres are maintained by telomerase complexes, of whi...


A meta-analysis of the C1420T polymorphism in cytosolic serine hydroxymethyltransferase (SHMT1) among Caucasian colorectal cancer populations
Inconsistency of reported associations between the C1420T polymorphism in the cytosolic serine hydroxymethyltransferase (SHMT1) gene and colorectal cancer (CRC) prompted us to undertake a meta-analysis.We conducted searches of published literature in MEDLINE through PubMed up to April 2012. Indiv...
Incidence of -93 MLH1 promoter polymorphism in familialand sporadic colorectal cancer
The MLH1 promoter contains a common single nucleotide polymorphism (SNP) (-93Guanine>Adenine) located in anessential region for maximum transcriptional activity. This has been associated with an increased risk of microsatellite instability (MSI) colorectal cancer. The aim of the study was to comp...

Therapeutic DNA Vaccination Using In Vivo Electroporation Followed by Standard of Care Therapy in Patients With Genotype 1 Chronic Hepatitis C
Clearance of infections caused by the hepatitis C virus (HCV) correlates with HCV-specific T cell function. We therefore evaluated therapeutic vaccination in 12 patients with chronic HCV infection. Eight patients also underwent a subsequent standard-of-care (SOC) therapy with pegylated interferon...
Genetic modification of dividing cells using episomally maintained S/MAR DNA vectors
The development of episomally maintained DNA vectors to genetically modify dividing cells efficiently and stably, without the risk of integration-mediated genotoxicity, should prove to be a valuable tool in genetic research. In this study, we demonstrate the utility of Scaffold/Matrix Attachment ...

Integrated analysis of whole genome exon array and array-comparative genomic hybridization in gastric and colorectal cancer cells
Whole genome-scale integrated analyses of exon array and array-comparative genomic hybridization (CGH) are expected to enable the identification of unknown genetic features of cancer cells. Here, we evaluated this approach in 22 gastric and colorectal cancer cell lines, focusing on protein kinase...
Genetic variant in CASP3 affects promoter activity and risk of esophageal squamous cell carcinoma
Caspase-3 is the main executioner of apoptosis mediating both extrinsic and intrinsic cell death signaling pathways and involved in tumor behaviors. In this study, we investigated the association of two regulatory variants in caspase-3 and the risk of esophageal squamous cell carcinoma (ESCC) in ...

Potentially functional genetic variants in KDR gene as prognostic markers in patients with resected colorectal cancer
Angiogenesis plays a key role in the development and treatment response of various tumors. The signaling transductions mediated by the binding of VEGF to its receptor KDR is the most important pathway in tumor angiogenesis. Single nucleotide polymorphisms (SNPs) in VEGF have been extensively impl...